Lundbeck Integration Lead
We operate in more than 50 countries around the world. If your country is not on the list, please refer to our global contacts.
The acquisition of Alder Biopharmaceuticals will expand Lundbeck’s treatment portfolio into migraine prevention and represents a major step in the execution of our Expand and Invest to Grow strategy. We can now take part in helping the migraine community where so much unmet need remains.
Read the Press Release here.
Find out more about Migraine here.
11804 North Creek Parkway South, Bothell, WA 98011
+1 (425) 205 - 2900